Shawn Kwatra, MD
Johns Hopkins University
H-index: 37
North America-United States
Top articles of Shawn Kwatra, MD
Integrating skin color assessments into clinical practice and research: A review of current approaches
2024/2/9
No increased risk of postoperative adverse events in total joint replacement patients with hidradenitis suppurativa
Clinical and Experimental Dermatology
2024/2/3
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
Oncogene
2024/2/2
512-Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2
British Journal of Dermatology
2024/2
510-Dupilumab is efficacious in patients with prurigo nodularis regardless of stable use of topical corticosteroids and topical calcineurin inhibitors: pooled results from two …
British Journal of Dermatology
2024/2
526-Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study
British Journal of Dermatology
2024/2
Bedside greater occipital nerve block with bupivacaine for the treatment of recalcitrant scalp pruritus
JAAD Case Reports
2024/2/1
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study
Journal of the American Academy of Dermatology
2024/2/1
Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides
Scientific reports
2024/1/23
Dysregulation of the Skin–Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis
Genes
2024/1/23
Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort
British Journal of Dermatology
2024/1/23
Single-cell RNA sequencing reveals dysregulated POSTN+ WNT5A+ fibroblast subclusters in prurigo nodularis
Journal of Investigative Dermatology
2024/1/20
De novo autoimmune connective tissue disease and mortality in patients treated with anti-PD-1 and anti-PD-L1 therapy: a population-level cohort study
The British journal of dermatology
2024/4/28
Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo
JAMA dermatology
2024/1/17
Dupilumab therapy modulates circulating inflammatory mediators in patients with prurigo nodularis
JID Innovations
2024/4/12
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
Journal for Immunotherapy of Cancer
2024
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
JAAD International
2024/4/10
United States expert panel consensus on uniform nomenclature and diagnosis for neuropathic pruritus
Itch
2024/1/1
Rapid improvements in itch with tapinarof cream 1% once daily in two phase 3 trials in adults with mild to severe plaque psoriasis
Dermatology and Therapy
2024/1
Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood Type 2 inflammation.
JAAD International
2024/4/7